Literature DB >> 7871100

Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments.

E P Pälvimäki1, A Laakso, M Kuoppamäki, E Syvälahti, J Hietala.   

Abstract

Quantitative receptor autoradiography was used to study the effects of the selective serotonin reuptake inhibitors citalopram and fluoxetine and the tricyclic antidepressant imipramine on the regulation of beta 1-adrenergic receptors in the rat brain. Rats were treated with saline, citalopram (10 mg kg-1), fluoxetine (10 mg kg-1), or imipramine (15 mg kg-1) SC once daily for 14 days. [125I]Iodocyanopindolol binding to beta 1-adrenergic receptors was found to increase significantly in the caudate-putamen and the somatosensory areas of the frontal cortex after both citalopram and fluoxetine treatments. Imipramine treatment elicited a marked decrease in beta 1 binding in the outer laminae of the cingulate cortex, as well as in the motor and somatosensory areas of the frontal cortex. In a separate experiment, rats were treated with saline, citalopram (2.5, 10 and 20 mg kg-1) or fluoxetine (2.5, 10 and 20 mg kg-1) SC once daily for 14 days. The effects of citalopram and fluoxetine on beta 1 receptors in the somatosensory cortex and caudate-putamen were replicated. These results demonstrate that chronic administration of selective serotonin reuptake inhibitors, in contrast to imipramine, can cause a regional up-regulation of beta 1-adrenergic receptors in the rat brain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7871100     DOI: 10.1007/bf02245579

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain.

Authors:  D A Bergstrom; K J Kellar
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

2.  Chronic administration of sertraline, a selective serotonin uptake inhibitor, decreased the density of beta-adrenergic receptors in rat frontoparietal cortex.

Authors:  W F Byerley; E J McConnell; R T McCabe; T M Dawson; B I Grosser; J K Wamsley
Journal:  Brain Res       Date:  1987-09-22       Impact factor: 3.252

3.  Development of beta-adrenergic receptor subsensitivity by antidepressants.

Authors:  S P Banerjee; L S Kung; S J Riggi; S K Chanda
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

4.  Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.

Authors:  G A Ordway; C Gambarana; S M Tejani-Butt; P Areso; M Hauptmann; A Frazer
Journal:  J Pharmacol Exp Ther       Date:  1991-05       Impact factor: 4.030

5.  Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5-hydroxytryptamine uptake inhibitor citalopram.

Authors:  I Nalepa; J Vetulani
Journal:  J Neurochem       Date:  1993-06       Impact factor: 5.372

6.  Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.

Authors:  D A Bergstrom; K J Kellar
Journal:  J Pharmacol Exp Ther       Date:  1979-05       Impact factor: 4.030

7.  Chronic but not acute antidepressants interfere with serotonin (5-HT1B) receptors.

Authors:  H Frances; F Khidichian
Journal:  Eur J Pharmacol       Date:  1990-04-10       Impact factor: 4.432

8.  Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine.

Authors:  W F Byerley; E J McConnell; R T McCabe; T M Dawson; B I Grosser; J K Wamsley
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat.

Authors:  M B Assie; M Charveron; C Palmier; C Puozzo; C Moret; M Briley
Journal:  Neuropharmacology       Date:  1992-02       Impact factor: 5.250

Review 10.  Fluoxetine: a review of receptor and functional effects and their clinical implications.

Authors:  C M Beasley; D N Masica; J H Potvin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more
  12 in total

1.  FOCUS trial: results, potentialities and limits.

Authors:  Luca Saba; Antonella Balestrieri; Alessandra Serra; Raimondo Garau; Carola Politi; Pierleone Lucatelli; Alessandro Murgia; Jasjit S Suri; Lorenzo Mannelli
Journal:  Ann Transl Med       Date:  2019-07

2.  Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT.

Authors:  Martin Dennis; John Forbes; Catriona Graham; Maree Hackett; Graeme J Hankey; Allan House; Stephanie Lewis; Erik Lundström; Peter Sandercock; Gillian Mead
Journal:  Health Technol Assess       Date:  2020-05       Impact factor: 4.014

3.  Motor priming in neurorehabilitation.

Authors:  Mary Ellen Stoykov; Sangeetha Madhavan
Journal:  J Neurol Phys Ther       Date:  2015-01       Impact factor: 3.649

4.  Beta-adrenoceptors in the tree shrew brain. I. Distribution and characterization of [125I]iodocyanopindolol binding sites.

Authors:  G Flügge; O Ahrens; E Fuchs
Journal:  Cell Mol Neurobiol       Date:  1997-08       Impact factor: 5.046

Review 5.  Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

Authors:  Lynn A Legg; Ann-Sofie Rudberg; Xing Hua; Simiao Wu; Maree L Hackett; Russel Tilney; Linnea Lindgren; Mansur A Kutlubaev; Cheng-Fang Hsieh; Amanda J Barugh; Graeme J Hankey; Erik Lundström; Martin Dennis; Gillian E Mead
Journal:  Cochrane Database Syst Rev       Date:  2021-11-15

Review 6.  Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke.

Authors:  F Chollet; J Rigal; P Marque; M Barbieux-Guillot; N Raposo; V Fabry; J F Albucher; J Pariente; I Loubinoux
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-23       Impact factor: 5.081

7.  Cellular consequences of stress and depression.

Authors:  Eberhard Fuchs; Gabriele Flügge
Journal:  Dialogues Clin Neurosci       Date:  2004-06       Impact factor: 5.986

8.  Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

Authors:  Lynn A Legg; Russel Tilney; Cheng-Fang Hsieh; Simiao Wu; Erik Lundström; Ann-Sofie Rudberg; Mansur A Kutlubaev; Martin Dennis; Babak Soleimani; Amanda Barugh; Maree L Hackett; Graeme J Hankey; Gillian E Mead
Journal:  Cochrane Database Syst Rev       Date:  2019-11-26

Review 9.  Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

Authors:  Gillian E Mead; Cheng-Fang Hsieh; Rebecca Lee; Mansur A Kutlubaev; Anne Claxton; Graeme J Hankey; Maree L Hackett
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

10.  Modulation of premotor cortex response to sequence motor learning during escitalopram intake.

Authors:  Eóin N Molloy; Karsten Mueller; Nathalie Beinhölzl; Maria Blöchl; Fabian A Piecha; André Pampel; Christopher J Steele; Ulrike Scharrer; Gergana Zheleva; Ralf Regenthal; Bernhard Sehm; Vadim V Nikulin; Harald E Möller; Arno Villringer; Julia Sacher
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-04       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.